As of 2024-12-11, the EV/EBITDA ratio of Bio Rad Laboratories Inc (BIO) is 29.77. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BIO's latest enterprise value is 10,307.31 mil USD. BIO's TTM EBITDA according to its financial statements is 346.20 mil USD. Dividing these 2 quantities gives us the above BIO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 21.1x | 20.6x |
| Forward P/E multiples | 19.0x - 21.7x | 20.4x |
| Fair Price | 204.95 - 367.08 | 284.16 |
| Upside | -39.7% - 8.0% | -16.4% |
| Date | EV/EBITDA |
| 2024-12-10 | 29.83 |
| 2024-12-09 | 30.24 |
| 2024-12-06 | 28.61 |
| 2024-12-05 | 28.36 |
| 2024-12-04 | 29.66 |
| 2024-12-03 | 29.16 |
| 2024-12-02 | 29.68 |
| 2024-11-29 | 29.83 |
| 2024-11-27 | 29.66 |
| 2024-11-26 | 29.60 |
| 2024-11-25 | 29.47 |
| 2024-11-22 | 29.21 |
| 2024-11-21 | 28.62 |
| 2024-11-20 | 28.46 |
| 2024-11-19 | 28.22 |
| 2024-11-18 | 27.61 |
| 2024-11-15 | 28.19 |
| 2024-11-14 | 30.61 |
| 2024-11-13 | 31.66 |
| 2024-11-12 | 31.77 |
| 2024-11-11 | 31.88 |
| 2024-11-08 | 32.15 |
| 2024-11-07 | 32.44 |
| 2024-11-06 | 32.45 |
| 2024-11-05 | 32.56 |
| 2024-11-04 | 32.12 |
| 2024-11-01 | 32.08 |
| 2024-10-31 | 31.25 |
| 2024-10-30 | 29.02 |
| 2024-10-29 | 29.11 |
| 2024-10-28 | 28.86 |
| 2024-10-25 | 28.18 |
| 2024-10-24 | 28.82 |
| 2024-10-23 | 29.38 |
| 2024-10-22 | 29.77 |
| 2024-10-21 | 30.04 |
| 2024-10-18 | 30.30 |
| 2024-10-17 | 30.10 |
| 2024-10-16 | 28.96 |
| 2024-10-15 | 29.96 |
| 2024-10-14 | 29.87 |
| 2024-10-11 | 29.53 |
| 2024-10-10 | 29.25 |
| 2024-10-09 | 29.67 |
| 2024-10-08 | 29.72 |
| 2024-10-07 | 29.87 |
| 2024-10-04 | 30.08 |
| 2024-10-03 | 29.55 |
| 2024-10-02 | 29.99 |
| 2024-10-01 | 29.60 |